Pitt Shield

A Transmit-Receive Phased Array for Microbubble-Mediated Focused Ultrasound Brain Therapy in Small Animals.

Authors: Lin Y, McMahon D, Jones RM, Hynynen K

Focused ultrasound (FUS) combined with circulating microbubbles (MBs) can be employed for non-invasive, localized agent delivery across the blood-brain barrier (BBB). Previous work has demonstrated the feasibility of clinical-scale transmit-receive phased arrays for performing transcranial therapies under MB imaging feedback. This study aimed to design, construct, and evaluate a dual-mode phased array for MB-mediated FUS brain therapy in small animals. A 256-element sparse hemispherical array (100 mm diameter) was fabricated by installing 128 PZT cylinder transmitters (f<sub>0</sub> = 1.16 MHz) and 128 broadband PVDF receivers within a 3D-printed scaffold. The transmit array's focal size at the geometric focus was 0.8 mm × 0.8 mm × 1.7 mm, with a 31 mm/27 mm (lateral/axial) steering range. The receive array's point spread function was 0.6 mm × 0.6 mm × 1.5 mm (1.16 MHz source) at the geometric focus, and sources were localized up to 30 mm/16 mm (lateral/axial) from geometric focus. The array was able to spatially map MB cloud activity in 3D throughout a vessel-mimicking phantom at sub-, ultra-, and second-harmonic frequencies. Preliminary in-vivo work demonstrated its ability to induce localized BBB permeability changes under 3D sub-harmonic MB imaging feedback in a mouse model. Small form factor transmit-receive phased arrays enable acoustic imaging-controlled FUS and MB-mediated brain therapies with high targeting precision required for rodent studies. Dual-mode phased arrays dedicated for small animal use will facilitate high-throughput studies of FUS-mediated BBB permeability enhancement to explore novel therapeutic strategies for future clinical application.

Introduction

Purpose drug delivery with BBB opening
Study Objective Design, construct, and evaluate a dual-mode sparse hemispherical phased array for microbubble-mediated focused ultrasound brain therapy in small animals with simultaneous 3D cavitation mapping via passive acoustic mapping
Animal model / Human subject mouse (CD-1, 20.9 g)
Disease model healthy
MRI or image guidance method Yes (7-T MRI)
Targeted brain region(s) Mid-Brain (Bilateral Locations)
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes The 256-element sparse hemispherical array (1.16 MHz) achieved transmit focal size 0.8×0.8×1.7 mm and steering range ±15 mm lateral. Receive array point spread function 0.6×0.6×1.5 mm. Enabled 3D passive acoustic mapping of microbubble activity at sub-, ultra-, and second-harmonic frequencies. Sub-harmonic imaging-based feedback controller triggered treatment at 0.49 MPa (calibration ramp) and reduced pressure to 0.25 MPa for treatment, inducing localized BBB opening in mouse brain (contrast-enhanced MRI) with less leakage than fixed-pressure exposure.
Safety-related matter No tissue damage reported. Feedback-controlled sonication produced less BBB leakage, potentially safer.

Brain Region

Ultrasound Parameters

Ultrasound instrument in-house fabricated 256-element sparse hemispherical array (128 PZT transmitters, 128 PVDF receivers), diameter 100 mm, 3D-printed scaffold
FUS Frequency 1.16MHz
FUS Pressure 0.46MPa
FUS Mode pulsed
Pulse duration 10ms
Duration of a single FUS session 240s
Focal Characteristics focal size (FWHM): 0.8 mm (lateral) × 0.8 mm (lateral) × 1.7 mm (axial); steering range: lateral ±15 mm, axial +8/-12 mm
Treatment frequency single session (two sonication locations)

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search